Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation - Wikidata - wikimedia - TriplyDB

Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation

Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation

http://www.wikidata.org/entity/Q34523170

about

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control Postoperative arrhythmias after cardiac surgery: incidence, risk factors, and therapeutic management Atrial fibrillation: current concepts Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat.Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial Management of atrial fibrillation: focus on the role of dronedarone.Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical framework Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.Vernakalant in the management of atrial fibrillation.Efficacy and safety of vernakalant in recent-onset atrial fibrillation after the European medicines agency approval: systematic review and meta-analysis.Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.Atrial Fibrillation Ablation: First-Line Therapy?Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial.Score associated with the outcome after multiple ablation procedures in patients with atrial fibrillation.Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors.Symptoms, acceptance of illness and health-related quality of life in patients with atrial fibrillation.Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.

P2860

Q24187110-965DA92A-6A0B-45D0-89B4-2A1427EA2C1A Q24197643-700BEFB0-DF56-4317-8D02-5F0FDDCAFE8D Q24243067-2D7203A5-4DD0-4E02-AEFB-D60DE9D6BC65 Q24800344-BD5338E5-1C0D-4DDD-B2B0-F4448AE3A08F Q26852436-D728C4FE-4F98-4D85-AC68-F0DB13F08459 Q34747164-112A23F5-F898-4B77-A62B-B5D43CFADE03 Q35826963-C17F1B2D-507A-4E63-9CA1-F202366352D1 Q36032636-374AC0E9-51E1-48DB-AC01-FD779A5F56D5 Q36581235-60469722-725E-428A-830F-12CDCD749960 Q37013160-E3947C5C-B909-4097-B023-7C0063064243 Q37018366-D4E9162E-9399-4148-98BF-600881D7AA11 Q37107714-5D5613F6-E34C-4E99-99AE-10F8E933EB12 Q37968223-4D90EDE4-055A-4202-8494-EF6638D0D73B Q38510915-B15C7E27-D74B-4439-B39B-FBFD3E721168 Q39300446-28723248-7B35-4690-A241-56420D9655E2 Q41974132-ABC2ED7D-4C6F-4A3D-899C-26ACDE47A32B Q44604522-01873BD4-D621-48ED-873F-58411207B0FF Q46312609-A9C5BB7A-10CE-455A-BBCE-EF7D5C059541 Q47192280-B35FAC6C-DFB9-4B7F-95E1-E24053ACEEB8 Q53065832-B9742BDD-0453-4FDD-8A24-E9A0CF26FCB8

P2860

Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation

http://www.wikidata.org/entity/Q34523170

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Meta-analysis of randomised co ...... ients with atrial fibrillation

@ast

Meta-analysis of randomised co ...... ients with atrial fibrillation

@en

Meta-analysis of randomised co ...... ients with atrial fibrillation

@nl

type

label

Meta-analysis of randomised co ...... ients with atrial fibrillation

@ast

Meta-analysis of randomised co ...... ients with atrial fibrillation

@en

Meta-analysis of randomised co ...... ients with atrial fibrillation

@nl

prefLabel

Meta-analysis of randomised co ...... ients with atrial fibrillation

@ast

Meta-analysis of randomised co ...... ients with atrial fibrillation

@en

Meta-analysis of randomised co ...... ients with atrial fibrillation

@nl

P1433

Q34523170-81BE5BC8-4030-4F11-AD19-A83E543BA0E1

P1476

Q34523170-21566F9A-45F8-48E2-A638-8C2226E99E88

P2093

Q34523170-32E242C9-20CE-4DA7-97F6-481D63DA0E4E

Q34523170-4F29A374-4026-4DF4-9BEC-FBB620A8AFCF

Q34523170-519794BF-999D-4D2E-8A9B-9C1998588EA6

Q34523170-6CED4962-79E1-40FF-B08D-489D04540B58

Q34523170-95878E19-701E-46CF-A74F-35682F5D77EB

Q34523170-DECAA75A-A431-4BDD-BF71-C0F233B22740

Q34523170-E5E0AFD4-9C6A-4CD6-AA1C-AFF836CCF99A

Q34523170-FDD8090F-BF73-4F47-AD76-AAE79CF663ED

P2860

Q34523170-02594E7E-55D3-479C-BDC7-28819513A23D

Q34523170-027E8660-38C9-4A8E-9C1A-095E9917BBD2

Q34523170-06DB525B-F11D-4376-A731-510548F63D9D

Q34523170-08ADD292-383A-4DFC-B7F3-FB3B31F7E937

Q34523170-0F87C653-EBB7-42F8-9204-9E40DF495815

Q34523170-12A9955F-1AAC-4CEF-992F-53B8B62C5D0B

Q34523170-13FB1429-C1EF-4639-905D-CECE71ED3251

Q34523170-1498294D-E509-41CD-83F3-35E3EFCBF25C

Q34523170-19FC418C-0EE6-4EBD-8629-A994C2FFF7DB

Q34523170-1BEC6BB9-9DFA-46D5-ADC6-ABDFD106D262

P304

Q34523170-357077E9-D08A-4A6B-BA08-05833C6E205C

P31

Q34523170-522aa21a-e452-4481-b518-03d4217d4351

Q34523170-8BA9C23C-FB93-45E4-9B00-B84C9C03B89F

P356

Q34523170-369C8B59-860F-4454-99BA-7107F7BBFEA7

P407

Q34523170-7F5FD7C1-8729-4E4A-B892-1A4DE25952A9

P433

Q34523170-0B109CFB-BEB8-453B-9E60-E32A66CA41A8

P478

Q34523170-6D021826-6AAA-4AA4-A10F-B2D7B80FF89E

P577

Q34523170-D37856E3-7499-47C0-B1CC-410861857F03

P5875

Q34523170-BAE26D58-B990-449D-BFFA-19C34374A312

P698

Q34523170-0032AC8B-2F6F-457A-9A3F-7FBB9F8E8E61

P921

Q34523170-D8E1AAFB-F241-481E-AE22-4ABC91BA9B24

P932

Q34523170-F43137D5-97AE-414B-8E20-A8C28DD8C7C3

P356

P1433

P1476

Meta-analysis of randomised co ...... ients with atrial fibrillation

@en

P2093

A Laupacis

http://www.w3.org/2001/XMLSchema#string

A Tang

http://www.w3.org/2001/XMLSchema#string

B Pham

http://www.w3.org/2001/XMLSchema#string

B Shea

http://www.w3.org/2001/XMLSchema#string

F McAlister

http://www.w3.org/2001/XMLSchema#string

G Nichol

http://www.w3.org/2001/XMLSchema#string

G Wells

http://www.w3.org/2001/XMLSchema#string

M Green

http://www.w3.org/2001/XMLSchema#string

P2860

When can odds ratios mislead? Odds ratios should be used only in case-control studies and logistic regression analyses

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery

Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Meta-analysis in clinical research

P304

535-543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HEART.87.6.535

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11360472

http://www.w3.org/2001/XMLSchema#string

P698

12010934

http://www.w3.org/2001/XMLSchema#string

P921

P932

1767130

http://www.w3.org/2001/XMLSchema#string